Henry Schein, Inc. to Post Q4 2017 Earnings of $1.97 Per Share, Jefferies Group Forecasts (HSIC)
Henry Schein, Inc. (NASDAQ:HSIC) – Jefferies Group cut their Q4 2017 EPS estimates for Henry Schein in a research report issued on Tuesday. Jefferies Group analyst B. Couillard now anticipates that the company will earn $1.97 per share for the quarter, down from their previous estimate of $2.02. Jefferies Group has a “Hold” rating and a $177.00 price target on the stock. Jefferies Group also issued estimates for Henry Schein’s Q1 2018 earnings at $1.90 EPS, Q2 2018 earnings at $2.02 EPS, Q3 2018 earnings at $1.98 EPS and Q4 2018 earnings at $2.15 EPS.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.73 by $0.02. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The company had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. During the same quarter in the prior year, the firm posted $1.64 EPS. Henry Schein’s quarterly revenue was up 6.4% compared to the same quarter last year. TRADEMARK VIOLATION WARNING: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/24/henry-schein-inc-to-post-q4-2017-earnings-of-1-97-per-share-jefferies-group-forecasts-hsic.html.
Other equities research analysts have also recently issued research reports about the company. Stifel Nicolaus restated a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. Barrington Research raised their price objective on Henry Schein from $196.00 to $198.00 and gave the stock an “outperform” rating in a report on Wednesday, May 10th. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price objective on the stock in a report on Monday, August 7th. Finally, Piper Jaffray Companies began coverage on Henry Schein in a report on Monday, June 12th. They set a “neutral” rating and a $200.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $185.56.
Shares of Henry Schein (NASDAQ HSIC) opened at 170.46 on Thursday. The company’s 50-day moving average price is $178.60 and its 200 day moving average price is $175.81. The stock has a market cap of $13.48 billion, a price-to-earnings ratio of 24.91 and a beta of 1.09. Henry Schein has a 12-month low of $146.23 and a 12-month high of $186.99. Henry Schein shares are set to split on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly created shares will be payable to shareholders after the closing bell on Thursday, September 14th.
Hedge funds and other institutional investors have recently modified their holdings of the stock. YorkBridge Wealth Partners LLC boosted its position in shares of Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after buying an additional 28 shares during the last quarter. Sun Life Financial INC boosted its position in shares of Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock worth $106,000 after buying an additional 573 shares during the last quarter. SpiderRock Advisors LLC purchased a new position in shares of Henry Schein during the first quarter worth $102,000. Lee Financial Co purchased a new position in shares of Henry Schein during the second quarter worth $161,000. Finally, JNBA Financial Advisors purchased a new position in shares of Henry Schein during the first quarter worth $170,000. Hedge funds and other institutional investors own 90.60% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.